Back to Treatments

Treatment

Meropenem

2
Conditions
81
Trials
9,500
Participants
68%
Average Safety

Condition Evidence

Invasive Non-typhoidal Salmonella (iNTS)

80 trials · 8,000 participants

95% effectiveness · 65% safety

Typhoid fever

1 trials · 1,500 participants

96% effectiveness · 70% safety
Meropenem | DFDA